Description
- Indicated for the treatment of subclinical mastitis caused by susceptible strains of Staphylococcus aureus and Streptococcus agalactiae in dry cows.
- Provides synergistic antibiotic combination of penicillin and novobiocin.
- Bactericidal activity against major Staphylococcus and Streptococcus mastitis pathogens.
- Ideal duration of activity during the involution phase of the dry cow period, when the keratin plug has not formed and the cow is susceptible to infections.
- Contents of 1 syringe are infused into each quarter at dry-off.
- 72-hour milk withhold following calving.
- 30-day pre-slaughter withdrawal required following administration.
- 12 x 10 ML syringes
Reviews
There are no reviews yet.